v3.26.3
Condensed Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development expenses $ 2,876 $ 2,585 $ 7,063 $ 8,033
Selling, general and administrative expenses 1,658 2,298 5,329 8,853
Loss from operations (4,534) (4,883) (12,392) (16,886)
Other income:        
Realized gains from sales of trading securities 174 208 621 873
Unrealized loss from trading securities (23) (39) (88) (312)
Interest income 16 175 47 589
Loss from disposition of property and equipment (4)
Total other income 167 344 576 1,150
Net loss $ (4,367) $ (4,539) $ (11,816) $ (15,736)
Net loss per basic common share $ (6.29) $ (7.89) $ (17.51) $ (27.22)
Net loss per diluted common share $ (6.29) $ (7.89) $ (17.51) $ (27.22)
Weighted average number of common shares outstanding:        
Basic 694 575 675 578
Diluted 694 575 675 578